Market Cap

Actinium Pharmaceuticals, Inc. Market Capitalization:

$207.6 Million

USD as of July 1, 2024

business Actinium Pharmaceuticals, Inc. Company Profile

Actinium Pharmaceuticals, Inc. Main Stock Listing

NYSE: ATNM

Market Capitalization History of Actinium Pharmaceuticals, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Actinium Pharmaceuticals, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $138.4 M -46.40%
Jan. 1, 2023 $258.3 M 96.86%
Jan. 1, 2022 $131.2 M -31.35%
Jan. 1, 2021 $191.1 M 4.65%
Jan. 1, 2020 $182.6 M -54.77%
Jan. 1, 2019 $403.8 M -21.16%
Jan. 1, 2018 $512.2 M -33.58%
Jan. 1, 2017 $771.2 M -50.00%
Jan. 1, 2016 $1.54 B -60.67%
Jan. 1, 2015 $3.92 B -5.44%
Jan. 1, 2014 $4.15 B 280.00%
Jan. 1, 2013 $1.09 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Actinium Pharmaceuticals, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Actinium Pharmaceuticals, Inc. has the following listings and related stock indices.


Stock: NYSE: ATNM

Stock: FSX: 7AY1

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.